The draft pharma policy’s plan to do away with loan licensing would lead to revenue loss for SMEs, disrupt the supply chain and make installed capacities redundant, says industry
…
The draft pharma policy’s plan to do away with loan licensing would lead to revenue loss for SMEs, disrupt the supply chain and make installed capacities redundant, says industry
…
While supporting the Union government for its programs like ‘Make in India’, and assuring that there will not be any compromise on quality aspects, the newly elected national president of the Indian Drugs Manufacturers’ Association (IDMA) said that nothing less than a Ministry for Pharmaceuticals…